Delivery Order SPE2DB20D1110-SPE2DB23FK37L
Award Date 8/29/23
Potential Completion Date 8/30/23
Potential Value $3.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,297.51 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg Emverm tablets to be delivered to a location in Conshohocken, Pennsylvania between August 10-11, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will fulfill the order for the chewable anti-parasitic drug tablets on behalf of the Defense Logistics Agency, the logistics combat support agency of the United States Department of Defense, to likely...
- The Defense Logistics Agency awarded a $1,235.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg EMVERM chewable tablets. As the prime contractor, Amerisourcebergen will deliver the prescription medication to an address in Conshohocken, Pennsylvania under a one-day period of performance between August 10-11, 2023. No subcontractors or set aside designations were indicated. The delivery order was issued against an existing DLA contract vehicle to support the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,492.00 to AmerisourceBergen Drug Corp for the supply of Emverm 100 mg tablet chewables under contract 4568864711. This firm fixed-price delivery order, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-competitive procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order falls under...
- The Defense Logistics Agency awarded a $18,281 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg Emverm tablets. As the prime contractor, Amerisourcebergen will provide approximately 18,000 tablets to support the Defense Logistics Agency's medical supply needs. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania distribution facility. The single day order period, July 17-18, 2023, aligns with the Defense Logistics Agency's mission to maintain...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,998.57 to AmerisourceBergen Drug Corp for the supply of Emverm 100 mg tablet chewable units, with a completion date of September 29, 2025. This non-set-aside award was issued on September 26, 2025, with performance to be fulfilled at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has been selected as...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $36,326.13 delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of issue on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a $39,912.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units on September 12, 2025, with completion targeted for September 15, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewables valued at $10,005.69 with an ultimate completion date of April 28, 2025. This is a firm fixed price, non-competitive delivery order with no set-aside designation, issued under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of single dose, valued at $17,223.18 under a firm fixed price contract type. This non-set-aside award was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. The product will be performed and delivered from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $65,417.77 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable unit dose supplies. This firm fixed-price delivery order, issued on August 19, 2025, represents a non-competitive set-aside contract with an ultimate completion date of August 20, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB23FK37LDelivery Order
The Defense Logistics Agency awarded a $3,943.53 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg chewable Emverm tablets. As the prime contractor, Amerisourcebergen will supply the anti-parasitic medication to support DLA's medical countermeasures programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in late August 2023. No subcontractors or set aside designations were identified. DLA routinely issues similar requirements to established pharmaceutical distributors and manufacturers to maintain critical drug stockpiles and fulfill emergency deployment needs.
Generated 12/24/23, 2:55 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 8/29/23 |